Trade Assembly Biosciences, Inc. - ASMB CFD

Add to favourite

13.5889

0.22%

View detailed chart

To be able to trade stocks like this, create an account and apply for a stock listing.

Create Account

Summary
Historical Data

Trading сonditions

Spread

0.2822

Long position overnight fee

-0.023512%

Short position overnight fee

0.00129%

Overnight fee time

22:00 (UTC)

Min traded quantity

Currency

USD

Margin

5.00%

Stock exchange

United States of America

Commission on trade

Key Stats

Prev. Close	13.6189
Open	13.7089
1-Year Change	1307.63%
Day's Range	13.4789 - 13.9889

Last Week
Last Month
Last Year
Last two Years
Max

Daily
Weekly
Monthly

Date	Close	Change	Change (%)	Open	High	Low
Feb 4, 2025	13.5889	-0.1200	-0.88%	13.7089	13.9889	13.4789
Feb 3, 2025	13.6189	-0.1400	-1.02%	13.7589	14.1989	13.5689
Jan 31, 2025	13.9589	-0.1900	-1.34%	14.1489	14.3689	13.7589
Jan 30, 2025	13.9989	0.1800	1.30%	13.8189	14.4489	13.8189
Jan 29, 2025	13.8089	-0.3200	-2.26%	14.1289	14.1689	13.5689
Jan 28, 2025	14.1289	0.3200	2.32%	13.8089	14.5389	13.7089
Jan 27, 2025	13.9089	-0.3700	-2.59%	14.2789	14.4589	13.5689
Jan 24, 2025	14.4789	0.2100	1.47%	14.2689	14.7489	14.2689
Jan 23, 2025	14.6389	0.1300	0.90%	14.5089	14.7289	14.2689
Jan 22, 2025	14.5189	0.2600	1.82%	14.2589	14.7389	14.2589
Jan 21, 2025	14.2589	-0.1900	-1.31%	14.4489	14.7589	14.1089
Jan 17, 2025	14.1789	0.0500	0.35%	14.1289	14.4489	14.1089
Jan 16, 2025	14.2589	-0.2100	-1.45%	14.4689	14.5789	14.1589
Jan 15, 2025	14.3189	0.1400	0.99%	14.1789	14.9589	14.1089
Jan 14, 2025	14.2489	-0.6100	-4.11%	14.8589	14.9589	14.1089
Jan 13, 2025	14.6989	-0.4700	-3.10%	15.1689	15.3089	14.4589
Jan 10, 2025	15.5689	-0.9100	-5.52%	16.4789	16.5689	14.9689
Jan 8, 2025	16.3889	-0.4700	-2.79%	16.8589	16.9089	16.3589
Jan 7, 2025	17.1289	0.1600	0.94%	16.9689	17.4589	16.3389
Jan 6, 2025	17.1589	-0.1200	-0.69%	17.2789	17.4589	16.2489

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission

1:1
2:1
3:1
5:1
10:1
20:1

Leverage

20:1

20
100
500
1000
10000

Investment

Trade size (Leverage x Investement):

Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

Assembly Biosciences, Inc. Company profile

About Assembly Biosciences Inc

Assembly Biosciences, Inc. is a clinical-stage biotechnology company advancing a class of oral therapeutic candidates for the treatment of chronic hepatitis B virus (HBV) infection. The Company’s inhibitor product candidates include Vebicorvir (VBR), ABI-H2158 (2158), and ABI-H3733 (3733). Vebicorvir (VBR) is licensed from Indiana University and treating patients with VBR plus nucelos(t)ide analog reverse transcriptase inhibitors (NrtIs) and ultimately transitioning patients. ABI-H2158 (2158) is chemically distinct from VBR. ABI-H3733 (3733) for chronic HBV infection in the People’s Republic of China, Hong Kong, Taiwan and Macau (the Territory). The Company’s research and development programs pursuing multiple drug candidates that inhibit the HBV replication cycle and block the generation of covalently closed circular DNA (cccDNA), to discover and develop finite and curative therapies for patients with HBV.

Financial summary

BRIEF: For the fiscal year ended 31 December 2021, Assembly Biosciences Inc revenues decreased 92% to $6.3M. Net loss increased from $62.2M to $129.9M. Revenues reflect a decrease in demand for the Company's products and services due to unfavorable market conditions. Higher net loss reflects Interest and other income, net decrease of 88% to $302K (income), Restructuring Charges & Provisions increase of 40% to $277K (expense).